Recombinant protein vaccine fails expectations for SARS-CoV-2 neutralization,

The researchers conducted the clinical trial across ten research centers in the United States and plan to complete the study a year after the last injection., The researchers conducted the clinical trial across ten research centers in the United States and plan to complete the study a year after the last injection., Read More

Scroll to Top